...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Updates

So we had the Jan 7th update and I sense Don was happy to get it done and to get shareholders off his back for another year.

My guess and expectation is that the next update will be January of 2017.

Perhaps in October or November of 2016 we might here about a successful or unsuccessful prostate proof of concept trial. It will be wonderful if it is successful and if so this will lead to years of clinical trials.

Perhaps, somewhere down the road the biotech investment sector will recover and that will remove Don's excuse for not getting on with an IPO after he missed (3 of ) 5 years of hot biotech stock performance. Sure would love to hear from Arthur Higgins about his brilliant spinco idea almost 3 years after the fact.

So if I recall Feb 1 is when the "name change" to ZCC is to be registered. Not sure that will have any significance but we'll see.

GLTA re liquidity of ZEL compounds. Sounded like a brilliant idea but........."where's the beef"?

A very frustrated...

Toinv

Share
New Message
Please login to post a reply